Publications of M. Osborn

Hossbach, M.; Gruber, J.; Osborn, M.; Weber, K.; Tuschl, T.: Gene silencing with siRNA duplexes composed of target-mRNA-complementary and partially palindromic or partially complementary single-stranded siRNAs. RNA Biology 3 (2), pp. 82 - 89 (2006)

Osborn, M.: IUBMB: the first half-century. Trends in Biochemical Sciences 30 (6), pp. 273 - 275 (2005)

Gruber, J.; Lampe, T.; Osborn, M.; Weber, K.: RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome. Journal of Cell Science 118, pp. 689 - 696 (2005)

Gruber, J.; Lampe, T.; Osborn, M.; Weber, K.: RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome. Journal of Cell Science 114 (4), pp. 689 - 696 (2005)

Gruber, J.; Manninga, H.; Tuschl, T.; Osborn, M.; Weber, K.: Specific RNAi Mediated Gene Knockdown in Zebrafish Cell Lines. RNA Biology 2, pp. 101 - 105 (2005)

Gruber, J.; Boese, G.; Tuschl, T.; Osborn, M.; Weber, K.: RNA interference by osmotic lysis of pinosomes: liposome independent transfection of siRNAs into mammalian cells. BioTechniques 37, pp. 96 - 102 (2004)

Taimen, P.; Parvinen, M.; Osborn, M.; Kallajoki, M.: NuMA in rat testis - Evidence for roles in proliferative activity and meiotic cell division. Experimental Cell Research 298, pp. 512 - 520 (2004)

Bechert, K.; Lagos-Quintana, M.; Harborth, J.; Weber, K.; Osborn, M.: Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells. Experimental Cell Research 286 (1), pp. 75 - 86 (2003)

Prelle, K.; Holtz, W.; Osborn, M.: Immunocytochemical analysis of vimentin expression patterns in porcine embryos suggests mesodermal differentiation from day 9 after conception. Anatomia Histologia Embryologia - Journal of Veterinary Medicine Series C 30 (6), pp. 339 - 344 (2001)

Domagala, W.; Welcker, M.; Chosia, M.; Karbowniczek, M.; Harezga, B.; Bartkova, J.; Bartek, J.; Osborn, M.: p21/WAF 1/Cip 1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, vimentin, cathepsin D and survival at 5 years. Virchows Archiv 439, pp. 132 - 140 (2001)

Quentmeier, H.; Osborn, M.; Reinhardt, J.; Zabroski, M.; Drexler, H.: Immunocytochemical analysis of cell lines derived from solid tumors. Journal of Histochemistry and Cytochemistry 49, pp. 1369 - 1378 (2001)

Harborth, J.; Weber, K.; Osborn, M.: GAS 41, a highly conserved protein in eukaryotic nuclei, binds to NuMA. Journal of Biological Chemistry 275, pp. 31979 - 31985 (2000)

Harborth, J.; Osborn, M.: Does NuMa have a scaffold function in the interphase nucleus. Critical Reviews in Eukaryotic Gene Expression 9 (3-4), pp. 319 - 328 (1999)

Harborth, J.; Wang, J.; Gueth-Hallonet, C.; Weber, K.; Osborn, M.: Self assembly of NuMA: multiarm oligomers as structural units of a nuclear lattice. EMBO Journal 18, pp. 1689 - 1700 (1999)

Gueth-Hallonet, C.; Wang, J.; Harborth, J.; Weber, K.; Osborn, M.: Induction of a regular nuclear lattice by overexpression of NuMA. Experimental Cell Research 243, pp. 434 - 452 (1998)

Scherfeld, D.; Schneider, G.; Guttmann, P.; Osborn, M.: Visualization of cytoskeletal elements in the transmission X-ray microscope. Journal of Structural Biology 123, pp. 72 - 82 (1998)

Gueth-Hallonet, C.; Weber, K.; Osborn, M.: Cleavage of the nuclear matrix protein NuMA during apoptosis. Experimental Cell Research 233 (1), pp. 21 - 24 (1997)

Seemann, J.; Weber, K.; Osborn, M.; Parton, R. G.; Gerke, V.: The association of annexin I with early endosomes is regulated by Ca2+ and requires an intact N-terminal domain. Molecular Biology of the Cell 7 (9), pp. 1359 - 1374 (1996)

Gueth-Hallonet, C.; Weber, K.; Osborn, M.: NuMA: A bipartite nuclear location signal and other functional properties of the tail domain. Experimental Cell Research 225 (1), pp. 207 - 218 (1996)

Domagala, W.; Markiewski, M.; Harezga, B.; Dukowicz, A.; Osborn, M.: Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: Its relationship with vimentin and p53 protein. Clinical Cancer Research 2 (1), pp. 147 - 154 (1996)